Stock News

Bristol Myers Squibb (BMY) Valuation Declined While Sabby Management Has Cut by $57.24 Million Its Stake; Gateway Investment Advisers Raised Its Intercontinental Exchange In (ICE) Holding by $426,168 as Share Price Declined

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Gateway Investment Advisers Llc increased its stake in Intercontinental Exchange In (ICE) by 1.18% based on its latest 2018Q1 regulatory filing with the SEC. Gateway Investment Advisers Llc bought 5,919 shares as the company’s stock declined 3.64% with the market. The institutional investor held 506,894 shares of the investment bankers and brokers and service company at the end of 2018Q1, valued at $36.76 million, up from 500,975 at the end of the previous reported quarter. Gateway Investment Advisers Llc who had been investing in Intercontinental Exchange In for a number of months, seems to be bullish on the $43.02B market cap company. The stock decreased 0.19% or $0.14 during the last trading session, reaching $74.27. About 1.76 million shares traded. Intercontinental Exchange, Inc. (NYSE:ICE) has risen 17.24% since June 20, 2017 and is uptrending. It has outperformed by 4.67% the S&P500. Some Historical ICE News: 19/03/2018 – Intercontinental Exchange Announces Transition of Credit Default Swap Open Interest from CME Group to ICE Clear Credit; Launches CDX Clearing at ICE Clear Europe; 19/03/2018 – NASDAQ BX REVOKES SELF-HELP AGAINST NYSE AMERICAN; 30/05/2018 – ICE – TRADING IN CO’S INTEREST RATE MARKET INCREASED AMID ONGOING POLITICAL UNCERTAINTY IN EUROPE COUPLED WITH CHANGES TO CENTRAL BANK MONETARY POLICY; 03/05/2018 – ICE 1Q REV LESS TRANSACTION EXP $1.2B, EST. $1.22B; 21/05/2018 – NYSE appoints Stacey Cunningham as first female president; 07/05/2018 – NYSE AMERICAN EQUITIES HAS REVOKED SELF-HELP AGAINST CHX; 07/03/2018 – ICE, FILES MIXED SECURITIES SHELF; 15/05/2018 – Coinbase plans revamp to lure institutional and high-speed traders; 04/04/2018 – INTERCONTINENTAL EXCHANGE INC – IN QTR, TOTAL FUTURES ADV UP 4% Y/Y; 28/03/2018 – CORRECTED-FACTBOX-Shanghai exchange plans China’s first crude oil futures

Hal Mintz decreased its stake in Bristol Myers Squibb (BMY) by 97.5% based on its latest 2018Q1 regulatory filing with the SEC. Sabby Management Llc sold 908,495 shares as the company’s stock declined 23.11% with the market. The hedge fund run by Hal Mintz held 23,312 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $1.47 million, down from 931,807 at the end of the previous reported quarter. Sabby Management Llc who had been investing in Bristol Myers Squibb for a number of months, seems to be less bullish one the $87.68 billion market cap company. The stock decreased 0.02% or $0.01 during the last trading session, reaching $53.64. About 5.47 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 2.98% since June 20, 2017 and is downtrending. It has underperformed by 15.55% the S&P500. Some Historical BMY News: 08/05/2018 – ACell, Inc. Names Nino Pionati Vice President, International and Business Development; 16/04/2018 – #AACR18 first-line NSCLC I/O showdown in NEJM $MRK Keynote-189; 12/03/2018 – Rhode Island DoA: Bristol Warren Regional School District Mon, 3/12/2018, 7:45 PM; 26/03/2018 – Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo Four-Week Dosing Schedule for Advanced Melanoma and Previously Treated Renal Cell Carcinoma; 17/05/2018 – INNATE PHARMA : Preliminary activity observed of the combination of monalizumab and durvalumab in patients with colorectal cancer; 13/03/2018 – MERCK & CO INC – SBLA FOR KEYTRUDA IS BASED IN PART ON DATA FROM PHASE 2 KEYNOTE-158 TRIAL; 23/03/2018 – INNATE PHARMA SA – PARTNER MEDIMMUNE EXPANDS COLORECTAL CANCER PATIENT COHORT IN ONGOING PHASE l TRIAL EVALUATING MONALIZUMAB IN COMBINATION WITH IMFINZI® (DURVALUMAB); 08/05/2018 – NEON THERAPEUTICS ANNOUNCES FIRST PATIENT TREATED IN CLINICAL TRIAL EVALUATING PERSONAL CANCER VACCINE NEO-PV-01 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) AND CHEMOTHERAPY; 23/03/2018 – lpsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma; 03/05/2018 – EMA VALIDATES BRISTOL-MYERS SQUIBB’S TYPE II VARIATION APPLICAT

Investors sentiment decreased to 0.87 in Q1 2018. Its down 0.41, from 1.28 in 2017Q4. It dropped, as 45 investors sold ICE shares while 258 reduced holdings. 73 funds opened positions while 191 raised stakes. 486.05 million shares or 2.19% less from 496.95 million shares in 2017Q4 were reported. Intact Inv owns 3,000 shares or 0.01% of their US portfolio. Tcw Gru Incorporated invested in 2.42M shares or 1.43% of the stock. Korea Investment stated it has 0.17% of its portfolio in Intercontinental Exchange, Inc. (NYSE:ICE). Brinker Cap has invested 0.17% in Intercontinental Exchange, Inc. (NYSE:ICE). Adams Diversified Equity Fund invested 1.51% of its portfolio in Intercontinental Exchange, Inc. (NYSE:ICE). Cognios Capital Limited Liability has invested 0.74% in Intercontinental Exchange, Inc. (NYSE:ICE). Manchester Mngmt Limited Liability Company owns 2,300 shares. The Vermont-based Prentiss Smith And has invested 0% in Intercontinental Exchange, Inc. (NYSE:ICE). Cubist Systematic Strategies Limited Liability Com reported 4,869 shares. First In stated it has 1,275 shares or 0.07% of all its holdings. Wealthtrust invested in 538 shares or 0.02% of the stock. Cortland Assocs Mo owns 590,489 shares for 7.55% of their portfolio. Tiverton Asset Mgmt Lc holds 1.1% or 217,784 shares. Ledyard State Bank reported 0.65% stake. British Columbia Inv Mngmt Corporation stated it has 0.17% in Intercontinental Exchange, Inc. (NYSE:ICE).

Gateway Investment Advisers Llc, which manages about $12.58 billion and $11.28 billion US Long portfolio, decreased its stake in Ebay Inc (NASDAQ:EBAY) by 12,703 shares to 609,616 shares, valued at $24.53 million in 2018Q1, according to the filing. It also reduced its holding in Netflix Inc (NASDAQ:NFLX) by 8,831 shares in the quarter, leaving it with 229,767 shares, and cut its stake in Whirlpool Corp (NYSE:WHR).

Among 20 analysts covering Intercontinental Exchange (NYSE:ICE), 17 have Buy rating, 0 Sell and 3 Hold. Therefore 85% are positive. Intercontinental Exchange had 69 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, June 6 by RBC Capital Markets. The stock has “Buy” rating by Keefe Bruyette & Woods on Thursday, November 2. J.P. Morgan upgraded the shares of ICE in report on Tuesday, February 20 to “Buy” rating. Deutsche Bank maintained the stock with “Buy” rating in Friday, April 6 report. The company was maintained on Thursday, February 8 by Keefe Bruyette & Woods. The firm has “Hold” rating by Argus Research given on Monday, November 2. The stock of Intercontinental Exchange, Inc. (NYSE:ICE) has “Buy” rating given on Friday, October 6 by Keefe Bruyette & Woods. The firm earned “Buy” rating on Monday, August 14 by RBC Capital Markets. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, March 31. The firm earned “Buy” rating on Monday, October 16 by RBC Capital Markets.

More notable recent Intercontinental Exchange, Inc. (NYSE:ICE) news were published by: Bizjournals.com which released: “Stacey Cunningham named president of NYSE Group” on May 23, 2018, also Seekingalpha.com with their article: “ICE to buy TMC Bonds for $685M cash” published on May 29, 2018, Seekingalpha.com published: “NYSE To Acquire Radiate For Business Video Platform” on June 11, 2018. More interesting news about Intercontinental Exchange, Inc. (NYSE:ICE) were released by: Seekingalpha.com and their article: “NYSE names Betty Liu executive vice chairman and will buy her firm Radiate” published on June 05, 2018 as well as Businesswire.com‘s news article titled: “ICE Gilt Futures Set Daily Volume Record of 1.4 Million Contracts” with publication date: May 25, 2018.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Bizjournals.com which released: “Why Big Pharma is finally discovering the Bay Area” on May 23, 2018, also Streetinsider.com with their article: “Bristol-Myers Squibb (BMY) Says China National Drug Administration Approved Country’s First Immuno-Oncology …” published on June 15, 2018, Seekingalpha.com published: “Neon Therapeutics readies IPO” on June 01, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Forbes.com and their article: “How Sensitive Is Bristol-Myers Squibb To Its R&D Expense Change?” published on June 05, 2018 as well as Seekingalpha.com‘s news article titled: “Nektar down 24% premarket on Opdivo + NKTR-214 data” with publication date: June 04, 2018.

Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.11, from 0.94 in 2017Q4. It dived, as 64 investors sold BMY shares while 573 reduced holdings. 111 funds opened positions while 418 raised stakes. 1.12 billion shares or 1.08% more from 1.11 billion shares in 2017Q4 were reported. First Mercantile Tru invested in 62,855 shares. Numerixs Technologies, British Columbia – Canada-based fund reported 6,638 shares. 11,407 are held by Gilman Hill Asset Management Limited Liability Company. Perritt Capital Mngmt Inc invested 0.09% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). 140,454 were reported by Sandy Spring Fincl Bank. Camarda Fincl Ltd Co reported 1.41% stake. S&Co reported 3.13% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Burns J W & Comm Inc Ny accumulated 141,200 shares or 2.29% of the stock. Mcmillion Capital Mgmt Incorporated holds 2.36% or 63,141 shares. Cetera Advsrs Limited Liability Corp has 73,159 shares for 0.27% of their portfolio. New York-based X Co Limited Company has invested 0.01% in Bristol-Myers Squibb Company (NYSE:BMY). Partner Ltd Partnership reported 55,719 shares or 3.81% of all its holdings. Baystate Wealth Management Ltd Company accumulated 0.01% or 837 shares. Thompson Rubinstein Investment Management Inc Or holds 9,600 shares. Somerville Kurt F reported 11,975 shares.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 2 Sell and 14 Hold. Therefore 27% are positive. Bristol-Myers Squibb Company had 87 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by UBS on Friday, October 6. The firm has “Buy” rating given on Tuesday, September 20 by Citigroup. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Jefferies on Thursday, August 27. The firm has “Hold” rating by UBS given on Monday, May 21. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Buy” rating given on Wednesday, December 2 by Guggenheim. Piper Jaffray maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Thursday, October 26. Piper Jaffray has “Hold” rating and $60.0 target. The firm has “Equal-Weight” rating given on Tuesday, April 17 by Morgan Stanley. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Sell” rating given on Wednesday, August 16 by BMO Capital Markets. The stock has “Buy” rating by UBS on Tuesday, September 29. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Friday, April 20 by Cowen & Co.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on July, 26. They expect $0.87 EPS, up 17.57% or $0.13 from last year’s $0.74 per share. BMY’s profit will be $1.42B for 15.41 P/E if the $0.87 EPS becomes a reality. After $0.94 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -7.45% negative EPS growth.

Sabby Management Llc, which manages about $835.79 million and $834.38 million US Long portfolio, upped its stake in Astrazeneca Plc (Put) by 869 shares to 8,380 shares, valued at $29.31M in 2018Q1, according to the filing. It also increased its holding in Sangamo Therapeutics Inc (Put) by 656 shares in the quarter, for a total of 3,386 shares, and has risen its stake in Incyte Corp (Put).

Since April 30, 2018, it had 1 buy, and 0 insider sales for $249,948 activity.

Intercontinental Exchange, Inc. (NYSE:ICE) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *